US FDA Warns of Liver Injury Cases Linked to Amgen’s Rare Disease Drug
The US Food and Drug Administration (FDA) has reported cases of liver injury in patients treated with Amgen’s drug Tavneos […]
Pharma
US FDA Expected to Lift Restrictions on Certain Peptides
The US Food and Drug Administration (FDA) is expected to lift restrictions on certain injectable peptides, which would allow compounding […]
Step Into India’s Fastest-Growing Pharma Hub: The Biggest Pharma Exhibition in Hyderabad Awaits
India’s pharmaceutical industry is entering a decisive phase, driven by scale, innovation, and increasing global responsibility. In this evolving landscape, […]
Lilly’s Eczema Drug Shows Durable Long-Term Response in Late-Stage Study
Eli Lilly said its eczema drug lebrikizumab (Ebglyss) showed durable long-term response in a late-stage study, with data highlighting sustained […]
EU Regulator Backs Sanofi’s Injectable Version of Blood Cancer Drug
Sanofi has received a positive recommendation from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) […]
India Pharma Expo Registration: Don’t Just Watch the Industry Evolve, Step Into It
There are events you attend and then there are platforms that change the way you see your industry. India Pharma […]
Biocon Appoints Shreehas P. Tambe as CEO & MD; Siddharth Mittal Steps Down
Biocon Limited has appointed Shreehas P. Tambe as its Chief Executive Officer and Managing Director, following the resignation of Siddharth […]
Corcept Therapeutics Receives US FDA Approval for Ovarian Cancer Drug
The US Food and Drug Administration (FDA) has approved Corcept Therapeutics’ relacorilant for the treatment of platinum-resistant epithelial ovarian cancer. […]
Your Gateway to Pharma Future: How to Register for India Pharma Expo 2026
India’s pharmaceutical sector is not just growing, it’s leading globally, contributing nearly 60% of the world’s vaccines and rapidly advancing […]
Hengrui’s Quarterly Profit Misses Estimates Amid Generic Drug Pressure
China-based drugmaker Jiangsu Hengrui Pharmaceuticals reported quarterly profit below market estimates, impacted by pressure on its generic drug business. The […]
Novo Nordisk Cuts Wegovy Price in South Africa for Second Time
Novo Nordisk has reduced the price of its semaglutide-based weight-loss drug Wegovy in South Africa for the second time since […]
Lupin Secures USFDA Tentative Approval for Pitolisant Tablets, Expands CNS Portfolio
Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) […]
Gilead to Acquire Ouro Medicines in Over $2 Billion Deal
Gilead Sciences has announced plans to acquire Ouro Medicines in a deal valued at over $2 billion to expand its […]
